Expert insights. Personalized for you.
Pharmaceutical Related Topics 
Veriheal
APRIL 11, 2022
The final goal is to introduce medicinal cannabis products to the pharmaceutical drug market. This means that the medical and scientific communities can now celebrate broader access to research for the production of pharmaceutical products that are safer than smokable or vaporizable cannabis.
Cannabis Life Network
MARCH 31, 2021
Because of its broad range of effects, cannabis can cause a variety of interactions with pharmaceutical drugs. The post How does cannabis interact with pharmaceutical drugs? A drug interaction happens when two or more compounds come in contact with each other and create an effect.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Fresh Toast
NOVEMBER 21, 2020
More Women Switch Out Pharmaceuticals For Medical Marijuana. The post More Women Switch Out Pharmaceuticals For Medical Marijuana appeared first on The Fresh Toast. Medical Marijuana News Endometriosis gynecology menopause pharmaceuticals prescription drugs women
Cannabis Law Report
MARCH 21, 2022
The Global Cannabis Pharmaceuticals Market size was estimated at USD 872.57 Growing usage of cannabis-based pharmaceuticals for various indications such as inflammation, chronic pain, sleep disorders, and others. Botanix Pharmaceuticals. Corbus Pharmaceuticals Holdings, Inc.
Cannabis Law Report
MARCH 9, 2021
While other cannabis industry SPAC’s have seemed to make big splashy entrances to the market, Ibere Pharmaceuticals quietly closed on… Read More. The post Ibere Pharmaceuticals Is The Quiet SPAC first appeared on Cannabis Law Report.
Cannabis Law Report
MARCH 15, 2021
Endocannabinoid drug development company Corbus Pharmaceuticals Holdings, Inc. The post Corbus Pharmaceuticals Beats Estimates For Fourth Quarter appeared first on Cannabis Law Report. NASDAQ: CRBP) reported financial results for the fourth quarter and year-end 2020.…
Cannabis Law Report
MAY 16, 2022
–(BUSINESS WIRE)– #earnings — Virpax ® Pharmaceuticals, Inc. About Virpax Pharmaceuticals. VIRPAX PHARMACEUTICALS, INC. VIRPAX PHARMACEUTICALS, INC. VIRPAX PHARMACEUTICALS, INC.
Cannabis Law Report
MAY 12, 2021
BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc. Nasdaq: MYMD), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing… Read More. Business Wire
Cannabis Law Report
MARCH 31, 2022
–(BUSINESS WIRE)– #earnings — Virpax ® Pharmaceuticals, Inc. About Virpax Pharmaceuticals. VIRPAX PHARMACEUTICALS, INC. VIRPAX PHARMACEUTICALS, INC. VIRPAX PHARMACEUTICALS, INC. –Company Advances All Pre-Clinical Programs– BERWYN, Pa.–(BUSINESS
Cannabis Law Report
SEPTEMBER 2, 2021
In Europe, there is a clear trend towards the use of more precise formulations of unapproved cannabis products as well as pharmaceutical products. The use of cannabinoids in the treatment of medical conditions offers major opportunities and challenges to anyone operating in the space.
Cannabis Law Report
MARCH 18, 2021
Clever Leaves Partners with Leading European Pharmaceutical Company to Market EU-GMP Certified Medical Cannabis Products NEW YORK, March 17, 2021… Read More.
|
Cannabis Law Report
APRIL 6, 2022
MARSA, Malta–(BUSINESS WIRE)–A2W Pharma Ltd, a pharmaceutical company based in Malta, celebrates the opening of its new facility during a launch event on its premises today.
Cannabis Law Report
MARCH 16, 2022
The United States Cannabis Pharmaceuticals Market size was estimated at USD 168.41 Company Usability Profiles: The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Cannabis Pharmaceuticals Market, including.
Cannabis Law Report
JUNE 17, 2021
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) raised its full-year 2021 financial guidance based on the acquisition of GW Pharmaceuticals, which was bought on May 5, 2021. The post Jazz Pharmaceuticals Increases Guidance Based On GW Pharma Acquisition appeared first on Green Market Report.
Cannabis Law Report
DECEMBER 23, 2021
DUBLIN–(BUSINESS WIRE)– “The Pharmaceutical Cannabis Report: 2nd Edition” report has been added to ResearchAndMarkets.com’s offering. GW Pharmaceuticals.
Cannabis Law Report
JULY 23, 2021
Users are looking for safer alternatives to opioids, antidepressants, and arthritis relief. Green Entrepreneur
Cannabis Law Report
MAY 11, 2022
AUSTIN, Texas–(BUSINESS WIRE)– Anebulo Pharmaceuticals, Inc. About Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc.
Cannabis Law Report
MAY 12, 2020
GW Pharmaceuticals lost $8 million in its latest quarter – an improvement over the previous three-month period – but the United Kingdom-based medical cannabinoid company … Read More.
Cannabis Law Report
APRIL 13, 2021
Beckley Psytech, a private company dedicated to addressing neurological and psychiatric disorders through psychedelic medicine, has appointed ex-GW Pharmaceuticals CFO… Read More.
Cannabis Law Report
AUGUST 10, 2021
BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, today reported that its subsidiary Oravax Medical Inc.
Cannabis Law Report
MARCH 20, 2021
Algernon Pharmaceuticals Inc. CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (“Algernon”), a clinical stage pharmaceutical development company, is pleased to announce… Read More.
Cannabis Law Report
JUNE 7, 2021
BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, is set to join the Russell Microcap® Index at the conclusion of the 2021 Russell indexes annual reconstitution effective after the US market opens on June 28, according to a preliminary list of additions posted June 4. About MyMD Pharmaceuticals, Inc.
Cannabis Law Report
APRIL 16, 2021
Shares to commence trading on the Nasdaq Capital Market on April 19, 2021 under the new ticker symbol “MYMD“ Upon… Read More. Business Wire
Cannabis Law Report
JANUARY 4, 2022
–(BUSINESS WIRE)– #pharma –Virpax ® Pharmaceuticals, Inc. About Virpax Pharmaceuticals. BERWYN, Pa.–(BUSINESS
Cannabis Law Report
FEBRUARY 3, 2021
The post February 4 2021: Jim Cramer on Jazz Pharmaceuticals buying GW Pharma for $7.2 … Read More. billion first appeared on Cannabis Law Report. Cannabis Law TV
Cannabis Law Report
MAY 18, 2022
DUBLIN–(BUSINESS WIRE)–The “Royalty Rates for Pharmaceuticals & Biotechnology, 9th Edition” report has been added to ResearchAndMarkets.com’s offering.
Cannabis Law Report
DECEMBER 15, 2021
The C³ business develops and manufactures pharmaceutical products and is comprised of Spectrum Therapeutics GmbH, based in Neumarkt-in-der-Oberpfalz, Germany , THC Pharm GmbH The Health Concept, based in Frankfurt, Germany , and Spectrum Therapeutics Austria GmbH, based in Vienna, Austria.
Cannabis Law Report
MAY 6, 2021
AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. Nasdaq: ANEB) (“Anebulo” or the “Company”), a clinical-stage biotechnology company developing novel solutions for people… Read More. Business Wire
Cannabis Law Report
MAY 5, 2022
–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. About Virpax Pharmaceuticals. BERWYN, Pa.–(BUSINESS
Cannabis Law Report
MARCH 26, 2022
Jazz Pharmaceuticals is investing £75m in a plant based at Kent Science Park (KSP) in Sittingbourne, Kent. The BBC Reports. Construction has begun on a medical cannabis manufacturing facility which will create more than 100 jobs.
Cannabis Law Report
DECEMBER 28, 2021
–(BUSINESS WIRE)– #pharma –Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX) achieved significant milestones relating to its pipeline of product candidates as of the end of 2021, which are summarized below. “I BERWYN, Pa.–(BUSINESS
Cannabis Law Report
JULY 7, 2021
BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. About MyMD Pharmaceuticals, Inc. MyMD is a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms.
Cannabis Law Report
FEBRUARY 3, 2021
The post February 4 2021: Jazz Pharmaceuticals buys GW Pharma for $7.2 … Read More. billion first appeared on Cannabis Law Report. Cannabis Law TV
Cannabis Law Report
OCTOBER 20, 2020
Here’s a quick blurb……… The rapid growth of cannabis-based medicines is becoming a significant disruptor of the global pharmaceutical industry, but the point of … Read More.
Cannabis Law Report
NOVEMBER 15, 2021
–(BUSINESS WIRE)– #earnings — Virpax ® Pharmaceuticals, Inc. Finally, we recently acquired the worldwide rights to VRP324, which is an intranasal pharmaceutical-grade cannabidiol product candidate for the management of epilepsy in children (rare pediatric disease) and adults.
Cannabis Law Report
FEBRUARY 23, 2022
The global cannabis pharmaceuticals market size is expected to reach USD 127.1 GW Pharmaceuticals. Valeant Pharmaceuticals. Such research studies are estimated to increase the demand for cannabis in the pharmaceutical industry. Synthetic Cannabis Pharmaceuticals Overview.
Cannabis Law Report
FEBRUARY 3, 2021
The post Jazz Pharmaceuticals Pick Up GW Pharma For A Cool $7.2 For those of you living under a rock here is the news. We thought we better report it along with… Read More. billion first appeared on Cannabis Law Report. Breaking News
83 
Let's personalize your content